Based off what I can see in the trading, I think that’s what investors are waiting for before this begins to rerate into phase 1, Walter Reed and FDA phase 2 over the period ahead. But also gives them cash to have a non stop runway and significant rerate that won’t be littered with cap raising risk. With their R&D I would imagine for the complete runway into phase 2 and non dilutive funding coming in as well a 2-3 million dollar raise is coming with a 10 percent discount to a 10 day VWAP which will be an excellent small raise which will see this rerate significantly short term and medium term. If they execute that raise then its game on
NYR Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)